approval · primary record
SPESOLIMAB-SBZO
FDA · BLA · 2025-10-21
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-21 |
| Brand | SPEVIGO |
| Sponsor | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:15.726Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:SPESOLIMAB-SBZO:2025-10-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.